HK1165491A1 - Method for producing platelets - Google Patents

Method for producing platelets

Info

Publication number
HK1165491A1
HK1165491A1 HK12106208.1A HK12106208A HK1165491A1 HK 1165491 A1 HK1165491 A1 HK 1165491A1 HK 12106208 A HK12106208 A HK 12106208A HK 1165491 A1 HK1165491 A1 HK 1165491A1
Authority
HK
Hong Kong
Prior art keywords
producing platelets
platelets
producing
Prior art date
Application number
HK12106208.1A
Other languages
English (en)
Chinese (zh)
Inventor
.巴呂什
.克拉梅爾-博爾德
.迪努瓦-拉德
Original Assignee
國家醫療保健研究所
雷卡爾巴黎大學
巴黎公共救濟院
凡爾賽大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 國家醫療保健研究所, 雷卡爾巴黎大學, 巴黎公共救濟院, 凡爾賽大學 filed Critical 國家醫療保健研究所
Publication of HK1165491A1 publication Critical patent/HK1165491A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0644Platelets; Megakaryocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/125Stem cell factor [SCF], c-kit ligand [KL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/145Thrombopoietin [TPO]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2521/00Culture process characterised by the use of hydrostatic pressure, flow or shear forces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK12106208.1A 2008-12-04 2012-06-25 Method for producing platelets HK1165491A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08305881 2008-12-04
PCT/EP2009/066401 WO2010063823A1 (en) 2008-12-04 2009-12-04 Method for producing platelets

Publications (1)

Publication Number Publication Date
HK1165491A1 true HK1165491A1 (en) 2012-10-05

Family

ID=40756593

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12106208.1A HK1165491A1 (en) 2008-12-04 2012-06-25 Method for producing platelets

Country Status (17)

Country Link
US (1) US9012221B2 (pt)
EP (1) EP2352815B1 (pt)
JP (1) JP5863459B2 (pt)
CN (2) CN102300984B (pt)
AU (1) AU2009324042B2 (pt)
BR (1) BRPI0922710A8 (pt)
CA (1) CA2745268C (pt)
CY (1) CY1117452T1 (pt)
DK (1) DK2352815T3 (pt)
ES (1) ES2569610T3 (pt)
HK (1) HK1165491A1 (pt)
HR (1) HRP20160404T8 (pt)
HU (1) HUE027112T2 (pt)
PL (1) PL2352815T3 (pt)
SI (1) SI2352815T1 (pt)
SM (1) SMT201600131B (pt)
WO (1) WO2010063823A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2686420B1 (en) * 2011-03-18 2017-03-01 New York Blood Center, Inc. Megakaryocyte and platelet production from stem cells
GB201210857D0 (en) 2012-06-19 2012-08-01 Cambridge Entpr Ltd Transcription factor mediated programming towards megakaryocytes
JP6584956B2 (ja) 2012-12-21 2019-10-02 アステラス インスティテュート フォー リジェネレイティブ メディシン 多能性幹細胞から血小板を生産するための方法およびその組成物
CA2896997C (en) * 2013-01-03 2023-10-03 Brigham And Women's Hospital, Inc. System and method for a biomimetic fluid processing
CN105980057B (zh) * 2013-11-19 2019-08-16 普拉托德公司 生产血小板的射流装置
JP2015181406A (ja) * 2014-03-24 2015-10-22 東レエンジニアリング株式会社 血小板産生装置および血小板産生方法
CA2944314C (en) * 2014-03-31 2023-09-19 Brigham And Women's Hospital, Inc. Systems and methods for biomimetic fluid processing
US10538738B2 (en) * 2014-05-19 2020-01-21 Eleftherios Papoutsakis Megakaryocytic particles and microparticles for cell therapy and fate modification of stem and progenitor cells
EP3294871A1 (en) 2015-05-12 2018-03-21 Platod Combination of pharmacological and microfluidic features for improved platelets production
WO2016204256A1 (ja) * 2015-06-16 2016-12-22 国立大学法人京都大学 高機能性血小板の製造方法
JP6859351B2 (ja) * 2015-09-08 2021-04-14 ブリガム・アンド・ウイミンズ・ホスピタル・インコーポレイテッド 血小板を産生するためのシステムおよび方法
WO2017047492A1 (ja) * 2015-09-15 2017-03-23 株式会社メガカリオン 回転式撹拌培養法による血小板の製造方法
EP3363443A4 (en) * 2015-10-14 2019-06-26 Megakaryon Corporation PROCESS FOR PRODUCING PURIFIED PLAQUETTES
SG11201803591UA (en) * 2015-11-02 2018-05-30 Megakaryon Corp Method for producing platelets using reciprocating stirring device
WO2018237061A1 (en) * 2017-06-20 2018-12-27 Northwestern University PLATELET MICROFLUIDIC BIOREACTOR DEVICE AND SYSTEMS
MX2020007071A (es) 2018-01-05 2020-11-11 Platelet Biogenesis Inc Composiciones y metodos para producir megacariocitos.
FR3101885A1 (fr) * 2019-10-11 2021-04-16 Etablissement Français Du Sang Systeme pour la liberation de plaquettes et procede de liberation de plaquettes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344560A (en) * 1979-11-02 1982-08-17 Asahi Kasei Kogyo Kabushiki Kaisha Container, apparatus and method for separating platelets
DE19956156A1 (de) * 1999-11-23 2001-06-13 Univ Eberhard Karls Verfahren zur Aufbereitung eines Präparates von Thrombozyten und Thrombozytenpräparat
EP1369128A1 (en) * 2002-06-07 2003-12-10 Procorde GmbH Inhibitors of glycoprotein VI and their therapeutic use
MX2007005200A (es) * 2004-11-01 2007-05-11 Wisconsin Alumni Res Found Plaquetas a partir de celulas germinales.
US7939277B2 (en) * 2005-01-14 2011-05-10 Umc Utrecht Holding Bv Methods and assays for distinguishing between different forms of diseases and disorders characterized by thrombocytopenia and/or by spontaneous interaction between Von Willebrand Factor (vWF) and platelets
JP5419076B2 (ja) * 2008-05-15 2014-02-19 旭化成メディカル株式会社 血小板の誘導方法

Also Published As

Publication number Publication date
BRPI0922710A8 (pt) 2018-06-26
SI2352815T1 (sl) 2016-10-28
CA2745268C (en) 2018-11-13
JP5863459B2 (ja) 2016-02-16
WO2010063823A1 (en) 2010-06-10
US9012221B2 (en) 2015-04-21
CN102300984A (zh) 2011-12-28
DK2352815T3 (en) 2016-05-17
HUE027112T2 (en) 2016-08-29
US20120014933A1 (en) 2012-01-19
HRP20160404T1 (hr) 2016-06-17
EP2352815A1 (en) 2011-08-10
AU2009324042A1 (en) 2011-07-07
ES2569610T3 (es) 2016-05-11
AU2009324042B2 (en) 2014-12-04
BRPI0922710A2 (pt) 2016-01-05
CN102300984B (zh) 2014-06-04
CY1117452T1 (el) 2017-04-26
HRP20160404T8 (hr) 2016-07-01
PL2352815T3 (pl) 2016-07-29
CA2745268A1 (en) 2010-06-10
SMT201600131B (it) 2016-07-01
EP2352815B1 (en) 2016-02-10
JP2012510804A (ja) 2012-05-17
CN104087552A (zh) 2014-10-08

Similar Documents

Publication Publication Date Title
HRP20160404T8 (hr) Metoda za proizvodnju trombocita
PL2252691T3 (pl) Sposób otrzymywania alfa-santalenu
ZA201007720B (en) Production method
GB0803107D0 (en) Method
EP2474560A4 (en) METHOD OF PREPARING AN 11 SUGAR SIALYLOLIGOSACCHARIDE PEPTIDE
EP2309823A4 (en) METHOD OF MANUFACTURING THE DEVICE
EP2332421A4 (en) PROCESS FOR PRODUCING MODIFIED MILK
EP2374789A4 (en) METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE
ZA201003678B (en) Methods for salt production
EP2328900A4 (en) PROCESS FOR PREPARING MORPHINAN-6 alpha-OLS
GB0804981D0 (en) Method
GB0804690D0 (en) Method
EP2221306A4 (en) PROCESS FOR PREPARING 2-AZAADAMANTANE
IL214287A0 (en) Method for producing 2-aminobiphenylene
EP2309852A4 (en) NOVEL PROCEDURE
EP2266943A4 (en) PROCESS FOR PRODUCING 2-ALKYL-2-CYCLOALCENE-1-ONE
EP2261262A4 (en) METHOD FOR PRODUCING POLYURONATE
IL210051A0 (en) Method for producing aminobiphenylene
ZA201009104B (en) Process for making substituted 2-amino-thiazolones
EP2321435A4 (en) WIEDERAUFKOHLUNGSVERFAHREN
EP2357247A4 (en) PROCESS FOR THE PRODUCTION OF POLY-3-HYDROXYALKANOATE
EP2259269A4 (en) METHOD FOR MANUFACTURING RADIOACTIVE STRONTIUM
PL2229430T3 (pl) Sposób wytwarzania węglowodorów
IL210353A0 (en) Method for producing phenylalkane - 1 - ols
EP2292599A4 (en) PROCESS FOR PRODUCING LAUROLACTAM

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20201210